Search company, investor...

COVID Technologies

Founded Year



Acquired | Acquired

About COVID Technologies

COVID Technologies was established with the mission to ensure Canadians are healthy and safe by providing Canadian-made vapor technology make in response to the COVOID-19 epidemic. On April 20th, 2020, COVID Technologies was acquired by Micron Waste. Terms of the transaction were not disclosed.

Headquarters Location

Vancouver, British Columbia,


Missing: COVID Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: COVID Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest COVID Technologies News

World Health Organisation reveals list of innovative Covid technologies

Sep 8, 2021

The World Health Organisation (WHO) has published a list of innovative technologies for Covid-19 and other diseases. The 24 technologies are considered to have an “immediate and future impact” on Covid-19 preparedness and response, according to a statement from the organisation (WHO). They also have the potential to improve health outcomes and offer a solution to an unmet medical need. The compendium of technologies includes tele-education for Covid-19 to connect experts to clinicians around the globe; a Covid vaccination e-voucher tool to better track vaccine enrolments; a portable respiratory monitoring system; and ventilators with an extended battery that can be used where electricity is not available or unstable. Dr Mariângela Simão, WHO assistant director general for access to health products, said: “Innovative technologies are accelerating access to healthcare everywhere, but we must ensure that they are readily available in all health facilities, fairly priced and quality-assured. “WHO will continue to work with governments, funders and manufacturers to promote sustainable supplies of these tools during and beyond the Covid emergency.” Some of the selected products are already addressing priority health problems in low-resource settings, according to the WHO. A “critical example” is a smartphone application that allows the user to record accurate blood pressure measurements, it said in a statement. The software-based platform transforms existing smartphones into a medical device capable of measuring blood pressure accurately. Hypertension has increased from 650 million to 1.28 billion in the last 30 years with many people unaware they have the condition – yet technology can play a part in diagnosing the condition sooner. Some 15 of the technologies are already commercially available. All technologies were assessed against WHO standards for performance, quality and safety, affordability and regulatory approval. A full list of the technologies and the reasons they were chosen can be found here. Related Posts

COVID Technologies Frequently Asked Questions (FAQ)

  • When was COVID Technologies founded?

    COVID Technologies was founded in 2020.

  • Where is COVID Technologies's headquarters?

    COVID Technologies's headquarters is located at Vancouver.

  • What is COVID Technologies's latest funding round?

    COVID Technologies's latest funding round is Acquired.

  • Who are the investors of COVID Technologies?

    Investors of COVID Technologies include Mircron Waste Technologies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.